Physio-Control Named a Medical Device Excellence Award Winner

Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), announced today that it has received a Gold Medical Design Excellence Award (MDEA) for its LIFEPAK^® 15 monitor/defibrillator. Physio-Control accepted the award at the MDEA ceremony held last week at the Medical Design & Manufacturing East 2009 Conference and Exposition in the Jacob K. Javits Convention Center, New York City.

The MDEA program recognizes both the design achievements and healthcare contributions of medical product manufacturers. Judges evaluate nominees based on product innovation, overcoming developmental challenges, design and engineering features and the impact made on improving healthcare.

"Physio-Control is honored to receive the Medical Design Excellence Award for the LIFEPAK 15 monitor/defibrillator,” said Brian Webster, president of Physio-Control. "We‘re very proud of the 15, which is the direct result of a collaborative effort between our emergency services customers and our product design and manufacturing teams. Not only is this unit extremely durable, helping it withstand extreme conditions in the field, but it continues to build on a 54-year Physio-Control legacy of providing innovative, reliable and quality products to emergency personnel worldwide.”

About Physio-Control

Physio-Control, a wholly-owned subsidiary of Medtronic, Inc., is located in Redmond, Wash. Physio-Control pioneered defibrillation technology more than 54 years ago. With nearly 800,000 Physio-Control products distributed worldwide, the company is the world’s leading provider of external defibrillation and monitoring technology for the treatment of sudden cardiac arrest and other cardio-respiratory emergencies. To find out more about Physio-Control, go to www.physio-control.com or call 1-800-442-1142.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s Annual Report on Form 10-K for the year ended April 25, 2008. Actual results may differ materially from anticipated results.